AKT1 and cancer: However, because lapatinib treatment caused some JAM-A downregulation and JAM-A levels have been shown to positively correlate with Akt phosphorylation [44], it is intriguing to speculate that JAM-A levels might independently regulate Akt phosphorylation in certain cancer settings.